Affiliation:
1. 1Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida.
2. 2Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida.
Abstract
Abstract
Background:
Cervical cancer disparities exist in the United States with the highest incidence in Hispanic women and the highest mortality in Black women. Effective control of cervical cancer in the population requires targeted interventions tailored to community composition in terms of race, ethnicity, and social determinants of health (SDOH).
Methods:
Using cancer registry and SDOH data, geospatial hot spot analyses were carried out to identify statistically significant neighborhood clusters with high numbers of cervical cancer cases within the catchment area of an NCI-Designated Cancer Center. The locations, racial and ethnic composition, and SDOH resources of these hot spots were used by the center's community outreach and engagement office to deploy mobile screening units (MSU) for intervention in communities with women facing heightened risk for cervical cancer.
Results:
Neighborhood hot spots with high numbers of cervical cancer cases in south Florida largely overlap with locations of poverty. Cervical cancer hot spots are associated with a high percentage of Hispanic cases and low SDOH status, including low income, housing tenure, and education attainment.
Conclusions:
A geospatially referenced cancer surveillance platform integrating cancer registry, SDOH, and cervical screening data can effectively identify targets for cervical cancer intervention in neighborhoods experiencing disparities.
Impact:
Guided with a data-driven surveillance system, MSUs proactively bringing prevention education and cervical screening to communities with more unscreened, at-risk women are an effective means for addressing disparities associated with cervical cancer control.
Publisher
American Association for Cancer Research (AACR)
Reference28 articles.
1. Cervical cancer statistics;Center for Disease Control and Prevention,2022
2. Cancers associated with human papillomavirus (HPV);Center for Disease Control and Prevention,2022
3. Gardasil;United States Food and Drug Administration,2023
4. HPV vaccination recommendations;Center for Disease Control and Prevention,2021
5. Cervical cancer: screening;US Preventive Services Task Force,2018